Allstate stock braces for the open after a 5% drop as CEO sale and broker downgrade hit ALL

Allstate stock braces for the open after a 5% drop as CEO sale and broker downgrade hit ALL

New York, Jan 14, 2026, 07:34 EST — Premarket

  • Shares of Allstate dropped 5.3%, ending Tuesday at $197.65. (Yahoo Finance)
  • CEO Thomas Wilson offloaded roughly $3.49 million in shares, following a pre-arranged trading plan, according to a recent filing. (Investing.com Canada)
  • TD Cowen downgraded Allstate from “buy” to “hold,” but raised its price target to $231. (Benzinga)

Shares of Allstate dropped 5.28% on Tuesday, closing at $197.65 on a volume near 4.46 million, per data from the company’s investor site. (Allstateinvestors)

The decline comes as Allstate approaches its next earnings report in early February, a key event that could shift outlooks on underwriting and investment returns. The insurer is set to release fourth-quarter results on Feb. 5, with the filing expected the day before. (Nasdaq)

Rate bets remain in focus. Tuesday’s U.S. inflation figures kept traders guessing on the timing of the next Federal Reserve cut, pushing Treasury yields slightly lower after the release. (Reuters)

A regulatory filing late Tuesday revealed that Chief Executive Thomas Wilson offloaded 16,807 shares on Jan. 12. The sale occurred under a Rule 10b5-1 trading plan established on June 27, 2025. (SEC)

A 10b5-1 plan is a pre-set trading arrangement allowing insiders to sell shares on a fixed timetable, shielding those transactions from daily news noise. On its own, it doesn’t reveal an executive’s stance on the stock.

TD Cowen cut Allstate to “hold” from “buy” on Monday but bumped up its price target to $231 from $224, according to a report outlining the note. (GuruFocus)

Tuesday’s drop at Allstate wasn’t unique in the insurance space. Progressive slid 5.25%, with Travelers and Chubb also retreating 3.30% and 1.94%, respectively, according to their most recent closing prices.

Catastrophe risk continues to simmer for property insurers, despite the spotlight often on ratings and insider trades. Munich Re reported that global insured losses from natural disasters hit $108 billion in 2025, cautioning that “a warming world makes extreme weather disasters more likely.” (Reuters)

The near-term risk remains straightforward: if claims trends or weather losses take a turn for the worse as the quarter ends, or if yields continue to fall, insurers could see their gains vanish fast after a solid rally.

Allstate is set to release its fourth-quarter earnings after 4:15 p.m. ET on Feb. 4, with a conference call scheduled for 9 a.m. ET on Feb. 5. (Allstatenewsroom)

Stock Market Today

  • Edwards Lifesciences eyes structural-heart growth after Critical Care sale
    January 14, 2026, 9:34 AM EST. Edwards Lifesciences EW aims to strengthen its balance sheet and expand a comprehensive structural heart portfolio after selling its Critical Care unit to Becton, Dickinson for $4.2 billion in cash. The move frees capital for investments in aortic, mitral, tricuspid and pulmonic therapies and supports long-term growth as it pivots from Critical Care. Investors are watching the pace of adoption for the PASCAL transcatheter repair system and the EVOQUE rollout, including a new 56-mm valve and Medicare's device payment add-on. The company shapes its growth around TAVR leadership and next-generation platforms, though macroeconomic risks and currency swings remain headwinds. Over the past year, EW lagged the industry and the S&P 500; Zacks ranks it Hold with a modest surprise history.
Rockwool stock steadies today after Russia takeover shock — buyback and February report now in focus
Previous Story

Rockwool stock steadies today after Russia takeover shock — buyback and February report now in focus

Mastercard stock steadies in premarket as Trump’s 10% credit-card cap talk keeps MA in focus
Next Story

Mastercard stock steadies in premarket as Trump’s 10% credit-card cap talk keeps MA in focus

Go toTop